neoadjuvant therapy

Open Access
Neoadjuvant Chemohormonal Therapy for Patients With Very-high Risk Localized Prostate Cancer in Clinical Stages T2 and T3a
DAIKI KIKUCHI, KAZUYUKI NUMAKURA, KOTONA MIYAUCHI, NORIYUKI ABE, MIYU OHTANI, SHIN KOBAYASHI and NAOKI WADA

In Vivo March 2026, 40 (2) 1098-1105; DOI: https://doi.org/10.21873/invivo.14264
Open Access
Survival Outcomes in Patients With Locally Advanced NSCLC Converted to Resectable Disease by Neoadjuvant Therapy
ECE DUYGU GULSEN, RASHAD ISMAYILOV, AYDAN FARZALIYEVA, MEHMET NEZIR RAMAZANOGLU, ARZU OGUZ, DALOKAY KILIC, ZAFER AKCALI and OZDEN ALTUNDAG

In Vivo January 2026, 40 (1) 522-531; DOI: https://doi.org/10.21873/invivo.14216
Open Access
Adjuvant Chemotherapy in Addition to Neoadjuvant Chemotherapy for Locally Advanced Non-small Cell Lung Cancer
RYO MIYATA, MASAYA AOKI, SHOICHIRO MORIZONO, TADASHI UMEHARA, AYA HARADA-TAKEDA, GO KAMIMURA, TOSHIYUKI NAGATA and KAZUHIRO UEDA

In Vivo September 2024, 38 (5) 2515-2522; DOI: https://doi.org/10.21873/invivo.13723
You have access
Micropapillary Bladder Cancer Metastatic to the Breast: A Case Report and Brief Literature Review
ELENA LIEVORE, LETTERIO RUNZA, MICHELE GHIDINI, BARBARA GALASSI, ANDREA GALLIOLI, CAROLINA BEBI, LUCA BOERI, CONCETTA BLUNDO, CLAUDIA FRANCESCA ROSSI, FABRIZIO LONGO, GIANCARLO ALBO, EMANUELE MONTANARI and ELISA DE LORENZIS

In Vivo January 2021, 35 (1) 453-459; DOI: https://doi.org/10.21873/invivo.12278
You have access
Prognostic Impact of the Neoadjuvant Rectal Score as Compared With the Tumor Regression Grade and Yield Pathologic TNM Stage in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy
JIN HO BAEK, DONG WON BAEK, BYUNG WOOG KANG, HYE JIN KIM, SU YEON PARK, JUN SEOK PARK, GYU SEOG CHOI and JONG GWANG KIM

In Vivo July 2020, 34 (4) 1993-1999; DOI: https://doi.org/10.21873/invivo.11997

Main menu

User menu

Search

neoadjuvant therapy